Steven Favaloro, incoming Genezen CEO (L) and Mark Womack, incoming BioCina CEO

March 16, 2023 11:33 AM EDT

Contract manufacturers BioCina and Genezen name new CEOs

Tyler Patchen

News Reporter

A pair of CDMOs are bringing in new CEOs.

Taking the helm at BioCina is Mark Womack. According to his LinkedIn

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

RFK Jr. ends annual Covid vaccine recommendations for kids, pregnant women

Investors pump $130M into protein degrader startup GlycoEra

Prothena’s amyloidosis drug flops again, spending and staff cuts are on the way

sponsored

From weeks to days: how Aizon Intelligent Agents transform pharma validation